info taken from Global Research, with thanks
See also 30/06/2021
FDA Lets Pfizer Test Experimental COVID-19 Vaccine on U.S. Children – Centre for Research onGlobalization
On Oct. 16, Pfizer’s CEO indicated the company would likely file for FDA Emergency Use Authorization for its experimental BNT162b2 vaccine in late November. That statement came three days after Pfizer announced that it had received FDA permission to administer the unproven vaccine to children as young as 12, becoming the first company in the U.S. to include young participants in Phase 3 trials.
View original post 528 more words